欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0279/001
药品名称Cefazolin-BCPP 1000mg powder for solution for injection/infusion
活性成分
    • cefazolin sodium salt 1000.0 mg
剂型Powder for solution for injection/infusion
上市许可持有人PharmSol Europe Limited The Victoria Centre Unit 2, Lower Ground Floor, Valletta Road, Mosta MST 9012, MALTA
参考成员国 - 产品名称Malta (MT)
Cefazolin-BCPP 1000mg Powder for solution for Injection/Infusion
互认成员国 - 产品名称
    • Germany (DE)
      Cefazolin PharmSol 1 g Pulver zur Herstellung einer Injektions-/Infusionslösung
    • Latvia (LV)
      Cefazolin PharmSol 1000 mg pulveris injekciju/infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Cefazolin PharmSol 1 g milteliai injekciniam ar infuziniam tirpalui
    • Slovenia (SI)
许可日期2020/07/01
最近更新日期2022/08/12
药物ATC编码
    • J01DB04 cefazolin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase